Japan· JP-4231400D2038
マイトマイシンＣ
A medicinal product containing マイトマイシンｃ, registered in Japan by 協和キリン, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- マイトマイシンＣ
- Manufacturer
- 協和キリン
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
マイトマイシンｃ in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMitomycinBluePoint Laboratories
- BelgiumMitomycin Accord Healthcare 10 mgAccord Healthcare
- United KingdomMitocin 20mg powder and solvent for intravesical solution vialsVygoris Ltd
- GermanyMitemSubstipharm
- CzechiaMITOMYCIN ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- SpainMITOMICINA ACCORD 10 MG POLVO PARA SOLUCION INTRAVESICAL Y PARA SOLUCION INYECTABLE EFGAccord Healthcare S.L.U.
- FinlandMitomycin AccordAccord Healthcare B.V.
- NetherlandsMitomycine Accord 10 mg, poeder voor oplossing voor injectie / infusie of intravesicaal gebruikAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Mitomycin Medac
- Belgium · Mitomycin Accord Healthcare, Mitomycin Medac
- Bulgaria · Митомицин Акорд
- Cyprus · Mitomycin Accord, Mitomycine Substipharm
- Czechia · Mitomycin Accord, Mitomycin Medac
- Germany · Mitem, Mito-Apogepha
- Denmark · Mitomycin Medac
- Estonia · Mitomycin Accord, Mitomycin Medac
- Spain · Mitomicina Accord, Mitomicina Aurovitas
- Finland · Mitomycin Accord, Mitomycin Medac
- France · Mitomycine Accord, Mitomycine Medac
- United Kingdom (Northern Ireland) · Mitocin, Mitomycin Accord Healthcare
- Ireland · Mitomycin Medac
- Iceland · Mitomycin Medac
- Italy · Mitomicina Accord, Mitomicina Medac
- Lithuania · Mitomycin Medac
- Latvia · Mitomycin Medac
- Malta · Mitomycine Substipharm
- Netherlands · Mitomycine Accord, Mitomycine Medac
- Norway · Mitomycin Medac, Mitomycin Substipharm
- Poland · Mitomycin Accord
- Portugal · Mitomicina Accord, Mitomicina Accord Healthcare
- Romania · Mitomicină Accord
- Sweden · Mitomycin Medac, Mitomycin Substipharm
- Slovenia · Mitomicin Accord, Mitomicin Medac
- Slovakia · Mitomycin Accord, Mitomycin Medac
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd17d8df-0cb3-4988-a4bf-ecb2d88ad13d GET /v1/drugs/fd17d8df-0cb3-4988-a4bf-ecb2d88ad13d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１０ｍｇ１瓶",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "4231400D2038",
"category": "注射薬",
"price_yen": 2196,
"generic_name": "マイトマイシンＣ",
"product_name_jp": null,
"therapeutic_class": "4231",
"transitional_expiry": null
}See everything about マイトマイシンｃ.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.